Liu, Jing <br/><br/>
Questions About a Clinical Trial Evaluating the Addition of Cetuximab to Definitive Chemoradiation Therapy With Paclitaxel and Cisplatin for Patients With Esophageal Cancer.  [electronic resource] 

 -  JAMA oncology  06 2018 
 - 887 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>2374-2445 
<br/><br/><label>Standard No.: </label>10.1001/jamaoncol.2018.0228  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cetuximab<br/>Chemoradiotherapy<br/>Cisplatin<br/>Esophageal Neoplasms<br/>Humans<br/>Paclitaxel